Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer
Clinical trial NCT01283789 · UNKNOWN
Trial details
- NCT number
- NCT01283789
- Sponsor
- University of Kansas Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2016-04-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.